Perspective Therapeutics, Inc.
PublicPerspective Therapeutics, Inc. is now publicly traded
The data on this page reflects Perspective Therapeutics, Inc.'s private-market history up to the point it went public, including its funding rounds, valuation, and investors.
Last Round
Private Placement
Mar 4, 2024
Total Funding Raised
$108.26M
Company Overview
Perspective Therapeutics, Inc. is based in Seattle. It has raised $108.26M.
Perspective Therapeutics, Inc. is a radiopharmaceutical development company that develops and commercializes precision targeted alpha therapies to treat cancer.
AI Layer
Non-AI
Perspective Therapeutics, Inc. Comparables
Compare Perspective Therapeutics, Inc. with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Z-Alpha Therapeutics | 74% | |
| Asta Bio | 69% | |
| Boomray Pharmaceuticals Co., Ltd. | 66% |
For institutional investors. Book with your work email.
Perspective Therapeutics, Inc. Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Private Placement | Mar 4, 2024 | ||||
| Follow-on Offering | Jan 8, 2024 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Perspective Therapeutics, Inc. Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Lantheus Alpha Therapy, LLC | Follow-on Offering |
Perspective Therapeutics, Inc. Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.